Skip to main content
. Author manuscript; available in PMC: 2013 Mar 7.
Published in final edited form as: Clin Lymphoma Myeloma Leuk. 2011 Aug;11(4):367–372. doi: 10.1016/j.clml.2011.06.005

Table 5.

CD73 Expression on Total T Lymphocytes and T-Lymphocyte Subsets in Patients With Early and Later Stage Disease

Variable Controls (SD) All Patients (SD) Stage 0–2 (SD) Stage 3–4 (SD)
T Lymphocytes 28.8 (6.6) 12.9a (11.1) 15.4a (12) 6.6a,b (3.7)
CD4+ 19.0 (6.5) 10.1a (6.2) 11.4a (8.1) 7.6a (2.1)
CD8+ 48.6 (18.6) 17.1a (13.9) 20.9a (7.6) 7.6a (10.8)

Abbreviation: SD = standard deviation.

a

2P < .0001 compared with control.

b

2P < .05 vs. stage 0–2.